Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease

A. J. H. Moonen, A. Wijers, A. F. G. Leentjens, C. W. Christine, S. A. Factor, J. Juncos, J. M. Lyness, L. Marsh, M. Panisset, R. Pfeiffer, D. Rottenberg, C. Serrano Ramos, L. Shulman, C. Singer, J. Slevin, W. McDonald, P. Auinger, I. H. Richard

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)644-646
JournalParkinsonism & Related Disorders
Issue number6
Publication statusPublished - Jun 2014


  • Parkinson's disease
  • Depression
  • Clinical trials randomized controlled
  • Venlafaxine
  • Paroxetine

Cite this